Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q3 2014 · 10-Q
Revenue—
Net Income$43.00K$43.00K+43.3% vs Q3 2013 EPS Diluted$0.00$0.00— vs Q3 2013 Operating Income$42,000+61.5% Operating Cash Flowderived$55,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 6, 2014 · 37 d after period end